Cite
HARVARD Citation
Memoli, M. et al. (2022). Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study. Leukemia & lymphoma. 63 (9), pp. 2171-2179. [Online].